Parkinson’s is a metabolic disease, can reverse naturally within a year, if the metabolic issue is resolved

This is a remarkable study, which not only convincingly demonstrates that Parkinson Disease (PD) is metabolic in origin, but also that PD can reverse on its own within 12 months if the metabolic issue is resolved. In other words, a disease we have been told by medicine for decades is largely of unknown cause (but, of course, genes are “implicated”) and is progressive/incurable/lethal, is actually very simple in origin, completely reversible, and (dare I say) remarkably simple to design a treatment for. The study also implicates a wide spectrum of ubiquitous chemicals in food that all can cause PD if a person is exposed to them on a regular basis. Namely, the study used the drug rotenone – a blocker of Complex I of the electron transport chain (ETC) – to cause PD in animals, but the study noted that the mechanism of rotenone is also present in a wide variety of chemicals including pesticides, to which regular people are exposed to on a daily basis (mostly through produce/food consumption). So, there we have it – all that is needed to produce PD is to interfere with mitochondrial function for a few weeks, and all that it takes for PD to reverse is removing the toxin exposure blocking mitochondrial function. The study findings also raise the very real possibility that substances, which can bypass the block at Complex I (or other ETC Complexes) or physically bind and thus deactivate the toxin, should also have similar therapeutic effects, even if the toxin exposure is still in place. Methylene blue, vitamin K, emodin, thymoquinone, etc can all bypass Complex I and restore mitochondrial respiration even if one or more of the ETC units are blocked.

https://doi.org/10.1016/j.isci.2026.117996

Rotenone-induced Parkinsonism in mice reverses within a year

“…For decades, researchers have pointed to mitochondria as a central culprit: impaired complex I activity, surging oxidative stress, and bioenergetic collapse appear consistently in animal models and in postmortem human brains. Epidemiological studies have repeatedly linked exposure to pesticides containing mitochondrial toxins, most notably rotenone and paraquat, to elevated Parkinson’s risk, but a definitive causal relationship has remained stubbornly out of reach, because the longitudinal studies needed to establish causation in humans are simply not feasible”

“…Rotenone, a potent and widely used complex I inhibitor, has long been the workhorse for testing the mitochondrial hypothesis in animals. The landmark rat studies showed that chronic rotenone infusion over one to five weeks could selectively kill substantia nigra neurons, seed α-synuclein aggregates resembling Lewy bodies, and produce hypokinesia.”

“…During the acute phase, the fourth week of treatment, the rotenone-treated mice looked unmistakably parkinsonian. In the open field test, they traveled dramatically shorter total distances, moved more slowly, spent less time mobile, and froze more often than controls. Their center-zone distance collapsed selectively, a classic signature of anxiety-like behavior, which the elevated plus maze confirmed: treated mice entered the open arms less often and spent less time there. This non-motor deficit matters, because anxiety frequently precedes motor dysfunction in human patients. The rotarod test revealed severely impaired motor balance and coordination, with treated mice falling far sooner than controls, and while control animals improved their performance over three weeks of training, the rotenone group actually got worse, pointing to disrupted motor learning. The Y-maze showed spatial working memory remained intact, mirroring the selective profile of early Parkinson’s. The cellular pathology in the midbrain was equally dramatic. Tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis, showed a strong reduction in fluorescence across the whole substantia nigra pars compacta, with the most severe loss in the middle ventral region, a subregional selectivity that recapitulates the pattern of degeneration seen in human Parkinson’s disease. ”

“…Then came the surprise that transforms this study from a model characterization into a story about biological resilience. Twelve months after the toxin was withdrawn, the rotenone-treated mice were behaviorally indistinguishable from controls. Open field locomotion, center-zone exploration, elevated plus maze performance, and rotarod latency had all normalized. The longitudinal analysis showed locomotion fully recovered within about four months, and rotarod performance converged with controls by seven months. Both groups declined with age, but the acute divergence between them vanished entirely. The Y-maze, already intact acutely, remained so. For a disease defined by irreversible neurodegeneration, the complete reversal of Parkinsonism in a mammalian brain is a genuinely unexpected result.”

Author: haidut